Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55

Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55

Abstract Umbilical cord blood transplantation (CBT) is accepted as an effective treatment for acute myeloid leukemia (AML), and reduced-intensity conditioning (RIC), rather than myeloablative conditioning (MAC) regimens allowed elderly patients to be treated safely. However, appropriate intensities...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shinichiro Oshima, Yasuyuki Arai, Tadakazu Kondo, Shingo Yano, Shigeki Hirabayashi, Naoyuki Uchida, Makoto Onizuka, Shigesaburo Miyakoshi, Masatsugu Tanaka, Satoshi Takahashi, Masayuki Hayashi, Toshiro Kawakita, Yasufumi Uehara, Shuichi Ota, Toru Izumi, Masashi Sawa, Tetsuya Nishida, Yuta Katayama, Koji Nagafuji, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada
Format: Artigo
Idioma:anglès
Publicat: 2025
Accés en línia:https://doi.org/10.1038/s41409-025-02508-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

https://doi.org/10.1038/s41409-025-02508-2

Ítems similars